Redesca · DIN 02509075 · 30 mg/0.3 mL · injection, 0.3 mL pre-filled syringe (preservative-free)
General benefitMarketed · checked November 20, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysODB senior: $100/program-year deductible
• Then up to $6.11 per prescription
Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
No interchangeable product listed in the Ontario extract
Redesca · DIN 02509075
Manufacturer: Shenzhen Techdow Pharmaceutical Co., Ltd.; listing date 2021-04-30
Health Canada: Marketed since 2021-04-09 · brand REDESCA · ATC B01AB05 ENOXAPARIN · form Solution · route Subcutaneous, Intravenous · ingredients ENOXAPARIN SODIUM 30 MG/0.3ML · company Shenzhen techdow pharmaceutical co., ltd. · schedule Prescription
Redesca: Formulary list price $4.96 per unit (the source does not state the unit; exact figure $4.9620). What the ministry pays, not the patient.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02509075)
Source record
DIN 02509075: Redesca
Raw flags: sec3=Y
Item: 201200106; group id 254; item number 0459; lccId None; manufacturer id SHE
Source form: Inj Sol-0.3mL Pref Syr (Preservative-Free); strength: 30mg/0.3mL
Recorded listing: General benefit
Source prices (unrounded): $4.9620; ministry $4.9620
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02509075
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=99839
Shortage status: not checked (no credentials)